Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Vi capsular polysaccharide vaccine"'
Autor:
To Nguyen Thi Nguyen, Maia A. Rabaa, Ho Ngoc Dan Thanh, Buddha Basnyat, Gordon Dougan, Sabina Dongol, Megan E Carey, Pham Thanh Duy, Abhilasha Karkey, Stephen Baker, Nga Tran Vu Thieu
Publikováno v:
PLoS Pathogens, Vol 16, Iss 10, p e1008998 (2020)
PLoS Pathogens
PLoS Pathogens
Despite recent advances in typhoid fever control, asymptomatic carriage of Salmonella Typhi in the gallbladder remains poorly understood. Aiming to understand if S. Typhi becomes genetically adapted for long-term colonisation in the gallbladder, we p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fa51080f11977df73ffc3261b7d3fd
https://www.repository.cam.ac.uk/handle/1810/312080
https://www.repository.cam.ac.uk/handle/1810/312080
Publikováno v:
Journal of Travel Medicine, 26(1)
Introduction Typhoid fever is a global health problem, causing significant morbidity and mortality. Currently, the most widely used vaccine is the typhoid Vi capsular polysaccharide (Vi-PS) vaccine. While epidemiological studies on its efficacy have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad5025c05f46ff34e7a57cef9dc6ae1
https://hdl.handle.net/1887/121441
https://hdl.handle.net/1887/121441
Publikováno v:
Scandinavian Journal of Immunology. 79:222-229
There are no vaccines in clinical use against paratyphoid fever, caused by Salmonella Paratyphi A and B or, rarely, C. Oral Salmonella Typhi Ty21a typhoid vaccine elicits a significant cross-reactive immune response against S. Paratyphi A and B, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce3eec16fe95e91f1b660581784d6b42
https://doi.org/10.1111/sji.12151
https://doi.org/10.1111/sji.12151
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Vaccine. 26:6639-6644
The Vi capsular polysaccharide vaccine is one of two vaccines against typhoid recommended worldwide and is the vaccine generally used in China. However, in recent years a Salmonella paratyphi A strain that is naturally devoid of capsule has caused fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137a9f58fb14e6b80e3bcbdfda4fca06
https://doi.org/10.1016/j.vaccine.2008.09.030
https://doi.org/10.1016/j.vaccine.2008.09.030
Autor:
John R Jones, E. Bateman, Siraj A. Misbah, Z. Sherrell, N. Groome, C. Banner, Helen Chapel, Berne Ferry, P. Stephens, H. Lythgoe
Publikováno v:
Clinical and Experimental Immunology. 136:297-303
SUMMARYWe have developed a solid-phase enzyme-linked immunosorbent assay (ELISA) to study the vaccination responses to Vi capsular polysaccharide of Salmonella typhi (S. typhi Vi) vaccine. Purified S. typhi Vi polysaccharide was biotinylated and boun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82834b96a1537abf72c003ff41a68072
https://doi.org/10.1111/j.1365-2249.2004.02439.x
https://doi.org/10.1111/j.1365-2249.2004.02439.x
Publikováno v:
Clinical Infectious Diseases. 38:771-779
Vaccines against Salmonella enterica serotype Typhi are used for prophylaxis of international travelers and have potential use as counterbioterrorism agents. The Vaccine Adverse Event Reporting System (VAERS) cannot usually establish causal relations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cbe1ea6384cbb86e16448c105f53732
https://doi.org/10.1086/381548
https://doi.org/10.1086/381548
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 18:609-620
Typhoid fever remains an important health threat in many parts of the world, with an estimated 16 million cases and 600,000 deaths occurring each year. The emergence of Salmonella typhi strains multiply resistant to antibiotics has complicated the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf321997641c18d63977e765971812fc
https://doi.org/10.1007/s100960050361
https://doi.org/10.1007/s100960050361
Publikováno v:
Vaccine. 14:435-438
The protective efficacy and immunogenicity of Vi capsular polysaccharide vaccine against typhoid fever was measured 3 years after its administration in a double-blind randomized trial. Vaccine efficacy was not significantly different during each year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4d68cfa4883e90ce564b4ac707978f
https://doi.org/10.1016/0264-410x(95)00186-5
https://doi.org/10.1016/0264-410x(95)00186-5
Publikováno v:
Vaccine. 20:3052-3054
Thyphoid fever is a disease predominant in underdeveloped and developing countries. Thyphoid fever is more prevalent, in fact endemic, in countries where fecal contamination of water and food sources are very common. The majority of the reported case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf22826aedfae29c3cdb7705370ff49
https://doi.org/10.1016/s0264-410x(02)00257-8
https://doi.org/10.1016/s0264-410x(02)00257-8